1043 IFN-γ + Tregs drive Trm-mediated toxicity and resistance in cancer immunotherapy

作者
Dipyaman Patra,Chenxian Ye,Katelyn Wolfgang,Kelsey M Ertwine,Jessica A Jana,Kristin M. Morder,Lora Heather Rigatti,Anthony Richard Cillo,Greg M. Delgoffe,Abigail E. Overacre-Delgoffe
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:: A1181-A1181
标识
DOI:10.1136/jitc-2025-sitc2025.1043
摘要

Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, 1 2 yet treatment resistance and immune-related adverse events (irAEs) in responders remain significant clinical challenges, and preclinical models remain limited.Methods To uncover mechanistic links between irAEs and ICI failure, we developed a novel murine model—Lifestyle-Induced Susceptibility to irAEs (LISA), which integrates diet-driven metabolic and microbial alterations to simulate human susceptibility to irAEs upon anti-PD-1 therapy. 3 4 This model faithfully recapitulates human disease in tissues impacted, susceptibility, severity, and treatment response.Results scRNA sequencing and flow cytometry analyses revealed tissue-specific expansion of inflammatory CD4 + and CD8+ tissue-resident memory T cells (Trms), marked by increased T-bet and Eomes expression, and a concurrent loss of reparative Trm subsets across impacted tissues, including the colon, liver, and skin. In contrast, tumors from the same mice exhibited a reciprocal immune profile, with reduction in cytotoxic Trms. These inflammatory signatures were strongly associated with an expansion of IFN-γ+ regulatory T cells (Tregs), which drove both systemic irAEs and reduced ICI efficacy.Dietary intervention restored Treg stability and prevented Trm reprogramming, thereby ameliorating both toxicity and therapeutic failure. Surprisingly, anti-LAG3 combination therapy enhanced both inflammatory and reparative Trms alongside IFN-γ+ Tregs, leading to improved tumor control without further aggravation of irAE symptoms. Finally, targeted deletion of IFN-γ or IFN-γ signaling specifically in Tregs (via Ifng L/L Foxp3 cre-YFP or Ifngr1 L/L Foxp3 cre-YFP) restored reparative Trms, suppressed inflammatory subsets, and significantly improved ICI response while reducing irAE incidence.Conclusions Our study reveals a novel immunoregulatory axis wherein IFN-γ-producing Tregs modulate tissue-resident T cell fate, thereby linking immune toxicity and resistance in ICI-treated hosts. These findings highlight the need for therapeutic strategies that balance Treg function and tissue inflammation to optimize immunotherapy outcomes.References Ferris RL, Blumenschein G, Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2023;375:1856–1867. 10.1056/NEJMoa1602252.Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutierrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N Engl J Med . 2022;386:24–34. 10.1056/NEJMoa2109970.Singh, RK, et al, Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15(1):73.Noverr MC, GB Huffnagle. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12(12):562–8.Ethics Approval All animal experiments were performed in the American Association for the Accreditation of Laboratory Animal Care-accredited specific-pathogen-free facilities in the Division of Laboratory Animal Resources at the University of Pittsburgh School of Medicine (UPSOM). All animal protocols were approved by the Institutional Animal Care and Use Committees of the University of Pittsburgh.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡然妙松发布了新的文献求助10
刚刚
精明丹妗发布了新的文献求助10
1秒前
Yaojiayin完成签到,获得积分10
2秒前
Kestis.完成签到,获得积分10
2秒前
钦川完成签到,获得积分10
3秒前
十七完成签到 ,获得积分10
3秒前
5秒前
SciGPT的应助被风吹水响采纳,获得10
5秒前
6秒前
充电宝的应助被风吹水响采纳,获得10
6秒前
111发布了新的文献求助10
6秒前
今后的应助被内向的鸽子采纳,获得10
7秒前
7秒前
ma关闭了ma的文献求助
8秒前
Felix完成签到,获得积分20
8秒前
CipherSage的应助被00hello00采纳,获得30
10秒前
2397发布了新的文献求助10
10秒前
2499297293发布了新的文献求助10
11秒前
XY发布了新的文献求助10
12秒前
岁0710发布了新的文献求助10
13秒前
13秒前
zdundun完成签到,获得积分10
14秒前
14秒前
14秒前
15秒前
16秒前
魏坤琳完成签到,获得积分20
16秒前
molihuakai的应助被2499297293采纳,获得10
16秒前
愉快的真发布了新的文献求助10
16秒前
热心夏天完成签到 ,获得积分10
16秒前
CodeCraft的应助被Kin采纳,获得10
16秒前
ftc完成签到,获得积分10
16秒前
Orange的应助被菲菲菲采纳,获得10
17秒前
hkp发布了新的文献求助10
17秒前
17秒前
苹果派完成签到 ,获得积分10
17秒前
童心完成签到,获得积分10
17秒前
19秒前
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193335
求助须知:如何正确求助?哪些是违规求助? 9579489
关于积分的说明 21865844
捐赠科研通 7792843
什么是DOI,文献DOI怎么找? 3437210
关于科研通互助平台的介绍 2560687
邀请新用户注册赠送积分活动 2483996